---
$id: https://graph.org.ai/products/commodity/51281645
$type: Product
source: UNSPSC
code: "51281645"
title: "Dibekacin sulfate"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dibekacin sulfate

**UNSPSC Code**: 51281645
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O8.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0869I992Z, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-2-deoxy-, sulfate (salt) but more generally known as dibekacin sulfate, which bears US NIH Compound Identifier 162862. European Medicines Agency schedules Dibekacin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01657MIG. Most nations, for tariff and trade purposes, schedule dibekacin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, DIBEKACIN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N.OS(=O)(=O)O.

